Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia
1 clinical trials · Condition
◉ Watch Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia (NCT00381680) | Children's Oncology Group | 2007-03-01 |
Track Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.